Literature DB >> 7430305

Determination of the concentration of adriamycin and its metabolites in the serum and tissues of Ehrlich carcinoma-bearing mice by high-performance liquid chromatography.

S Shinozawa, Y Mimaki, Y Araki, T Oda.   

Abstract

The concentration of adriamycin and its metabolites in serum and tissues was determined by high-performance liquid chromatography (HPLC) with a lapse of time after a single intraperitoneal administration to Ehrlich carcinoma-bearing mice. HPLC was carried out by using Zorbax Sil as the stationary phase and 3.8% sodium acetate in isopropanol as the mobile phase, at an excitation wavelength of 470 nm and an emission wavelength of 585 nm. Extraction of adriamycin using chloroform-methanol (4:1) gave recoveries of 98% from serum and 66-96% from tissues. Adriamycin rapidly disappeared from the serum, and the content of adriamycin per gram of tissue decreased in the order liver, duodenum, kidneys, spleen, lung, heart and tumour, and a high tissue retention occurred in the spleen and heart. The main metabolites of adriamycin were adriamycinone and adriamycinol, and other minor metabolites were detected.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7430305     DOI: 10.1016/s0021-9673(00)84748-2

Source DB:  PubMed          Journal:  J Chromatogr


  8 in total

1.  Quantification of Doxorubicin and metabolites in rat plasma and small volume tissue samples by liquid chromatography/electrospray tandem mass spectroscopy.

Authors:  Robert D Arnold; Jeanine E Slack; Robert M Straubinger
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2004-09-05       Impact factor: 3.205

2.  Tissue distribution of doxorubicin and doxorubicinol in rats receiving multiple doses of doxorubicin.

Authors:  J H Peters; G R Gordon; D Kashiwase; E M Acton
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

3.  Enhanced intracellular uptake of sterically stabilized liposomal Doxorubicin in vitro resulting in improved antitumor activity in vivo.

Authors:  Xiao-Bing Xiong; Yue Huang; Wan-Liang Lu; Hua Zhang; Xuan Zhang; Qiang Zhang
Journal:  Pharm Res       Date:  2005-06-08       Impact factor: 4.200

Review 4.  Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties.

Authors:  J Bouma; J H Beijnen; A Bult; W J Underberg
Journal:  Pharm Weekbl Sci       Date:  1986-04-25

5.  Analysis and pharmacokinetics of N-l-leucyldoxorubucin and metabolites in tissues of tumor-bearing BALB/c mice.

Authors:  J de Jong; I Klein; A Bast; W J van der Vijgh
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

6.  Comparative study of the in vitro and in vivo characteristics of cationic and neutral liposomes.

Authors:  Wei Zhao; Song Zhuang; Xian-Rong Qi
Journal:  Int J Nanomedicine       Date:  2011-12-01

7.  Cyclic RGD peptide-modified liposomal drug delivery system: enhanced cellular uptake in vitro and improved pharmacokinetics in rats.

Authors:  Zhongya Chen; Jiaxin Deng; Yan Zhao; Tao Tao
Journal:  Int J Nanomedicine       Date:  2012-07-18

8.  Visualisation of doxorubicin in human and animal tissues and in cell cultures by immunogold-silver staining.

Authors:  H P Henneberry; G W Aherne
Journal:  Br J Cancer       Date:  1992-01       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.